Granahan Investment Management - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 170 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.

Quarter-by-quarter ownership
Granahan Investment Management ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$7,550,000
+4.0%
731,558
+6.0%
0.14%
-8.4%
Q1 2021$7,263,000
-6.6%
690,410
+37.4%
0.15%
-12.0%
Q4 2020$7,779,000
+99.1%
502,542
+87.7%
0.18%
+31.6%
Q3 2020$3,908,000
-52.9%
267,697
-38.9%
0.13%
-55.7%
Q2 2020$8,297,000438,0810.30%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Consonance Capital Management LP 6,491,812$122,955,0007.37%
Fairmount Funds Management LLC 652,351$12,356,0005.51%
Palo Alto Investors LP 4,219,452$79,916,0004.80%
Avoro Capital Advisors LLC 7,000,000$132,580,0002.62%
Birchview Capital, LP 168,000$3,182,0001.92%
EMERALD ADVISERS, LLC 1,244,211$23,565,0001.03%
EMERALD MUTUAL FUND ADVISERS TRUST 1,036,947$19,640,0000.93%
Hood River Capital Management LLC 1,007,367$19,080,0000.86%
Atlas Private Wealth Advisors 48,640$921,0000.82%
SPHERA FUNDS MANAGEMENT LTD. 392,831$7,440,0000.70%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders